By Angela McDaniels
Tacoma, Wash., June 8 – Morgan Stanley priced $1 million of CMS curve range accrual securities due June 30, 2035 linked to the worst performing of the Russell 2000 index and the S&P 500 index, according to a 424B2 filing with the Securities and Exchange Commission.
The coupon is fixed at 9% for the first year. After that, it will be 9% per year multiplied by the proportion of days on which the spread of the 30-year Constant Maturity Swap rate over the two-year CMS rate is greater than or equal to zero and each index closes at or above its index reference level, 60% of its initial level. Interest is payable monthly.
If each index finishes at or above its barrier level, 50% of its initial level, the payout at maturity will be par. Otherwise, investors will be fully exposed to the decline of the worst-performing index.
Morgan Stanley & Co. LLC is the agent.
The issuer said it might increase the issue size prior to the settlement date, June 30, but is not required to do so.
Issuer: | Morgan Stanley
|
Issue: | CMS curve range accrual securities
|
Underlying indexes: | Russell 2000 and S&P 500
|
Amount: | $1 million
|
Maturity: | June 30, 2035
|
Coupon: | 9% for first year; after that, 9% per year multiplied by proportion of days on which spread of 30-year CMS rate over two-year CMS rate is greater than or equal to zero and each index closes at or above index reference level; payable monthly
|
Price: | Variable prices
|
Payout at maturity: | If each index finishes at or above barrier level, par; otherwise, full exposure to decline of worst-performing index
|
Initial levels: | Each index’s closing level on June 25
|
Index reference levels: | 60% of initial level
|
Barrier levels: | 50% of initial level
|
Pricing date: | June 4
|
Settlement date: | June 30
|
Agent: | Morgan Stanley & Co. LLC
|
Fees: | 3.7%
|
Cusip: | 61760QGK4
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.